Delivery Order SPE2DB22D2108-SPE2DB24FU3UK
- Not listed
- This is a $13,359.82 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of TRUVADA 200 MG-300 MG TABLET medication with an ultimate completion date of April 25, 2024. This order is placed under a larger Indefinite Delivery Contract (IDC) vehicle held by Amerisourcebergen with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31,...
- This is a $8,236.77 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of TRUVADA 200 MG-300 MG TABLET (National Stock Number 4560594908) and has an ultimate completion date of April 17, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary vehicle for...
- This is a $3,124.60 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Truvada 200 mg-300 mg tablets and has an ultimate completion date of February 25, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
- The U.S. government awarded a Firm Fixed Price Delivery Order contract worth $1,385.52 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Truvada 200-300mg tablets. This contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency, and has an ultimate completion date of July 6, 2023. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999, which serves as...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,224.76, is for the delivery of TRUVADA 200 MG-300 MG tablets. This is a firm fixed-price delivery order contract with no set-aside designation, indicating open competition. The contract appears to be part of a larger Indefinite Delivery Contract (IDC) vehicle valued at $999,999,999 that...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,292.52 firm fixed-price delivery order is for the supply of TRUVADA 200 MG-300 MG tablets. The contract has an ultimate completion date of March 4, 2025 and is not designated as a set-aside. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This is a $7,172.29 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The order is for the pharmaceutical product Truvada 200 mg-300 mg tablet, with a performance period through May 2024. The award is not associated with a set-aside program. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, including the Department of...
- This is a $13,110.60 firm-fixed-price delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the delivery of TRUVADA 200 MG-300 MG TABLET UU 30S, with a performance period through May 29, 2025. The contract is not set-aside and allows for the supply of a range of medical and pharmaceutical products, including medications across therapeutic areas such as diabetes, neurology, pain management,...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of TRUVADA 200 MG-300 MG TABLET medical products, with a ceiling value of $28,703.92 and a period of performance through December 15, 2023. This is a firm fixed-price delivery order contract, with no set-aside designation. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This is a federal contract award made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,917.37 firm fixed-price delivery order is for TRUVADA 200 MG-300 MG TABLET and has an ultimate completion date of March 25, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through...
- SPE2DB22D2108Indefinite Delivery Contract
- SPE2DB22D2108-SPE2DB24FU3UKDelivery Order
This is a $14,225.22 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the provision of TRUVADA 200 MG-300 MG TABLET pharmaceutical products, with a period of performance through April 25, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00 through December 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a wide range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. Amerisourcebergen also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024. The contract was awarded on a full and open competition basis without any set-aside designation. Amerisourcebergen's extensive pharmaceutical distribution capabilities and existing federal contract vehicles allow it to efficiently fulfill government requirements for critical medical products.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $14.2k | 4/24/24 |